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The liver and pancreas arise from common endo-
dermal progenitors. How these distinct cell fates
are specified is poorly understood. Here we describe
prostaglandin E2 (PGE2) as a regulator of endodermal
fate specification during development. Modulating
PGE2 activity has opposing effects on liver versus
pancreas specification in zebrafish embryos as
well as mouse endodermal progenitors. The PGE2
synthetic enzyme cox2a and receptor ep2a are
patterned such that cells closest to PGE2 synthesis
acquire a liver fate, whereas more distant cells
acquire a pancreas fate. PGE2 interacts with the
bmp2b pathway to regulate fate specification. At
later stages of development, PGE2 acting via the
ep4a receptor promotes outgrowth of both the liver
and pancreas. PGE2 remains important for adult
organ growth, as it modulates liver regeneration.
This work provides in vivo evidence that PGE2
may act as a morphogen to regulate cell-fate deci-
sions and outgrowth of the embryonic endodermal
anlagen.
INTRODUCTION
How multiple different cell types are generated from common
progenitors is a central question in developmental biology.
Understanding this process will have therapeutic significance
for repair of adult organs. One such context is the development
of distinct organs such as the liver, pancreas, lungs, and intestine
from the primordial gut endoderm. The specification and
outgrowth of these organs are regulated by a dynamic array of
signals including fibroblast growth factors (Fgfs), bone morpho-
genetic proteins (Bmps), retinoic acid, and sonic hedgehog
(Zaret and Grompe, 2008). Here we uncover the prostaglandin
pathway as a regulator of the specification and outgrowth of
the embryonic liver and pancreas.DevelopmWhereas the adult organs are histologically and functionally
distinct, the embryonic liver and pancreas are thought to arise
from a common population of endodermal cells. Experimental
support for this bipotential population comes from mouse
explant studies, as well as zebrafish cell-lineage studies. Endo-
derm explants from mouse embryos have the potential to give
rise to either liver or pancreatic progenitors depending on
extrinsic cues from adjacent mesoderm: Fgfs from the cardiac
mesoderm (Deutsch et al., 2001) or Bmps from the septum trans-
versummesenchyme (Rossi et al., 2001) induce hepatic differen-
tiation, whereas inhibition of these signals causes expression of
the pancreatic marker Pdx1 (Deutsch et al., 2001; Rossi et al.,
2001). Similarly, reciprocal effects on hepatic versus pancreatic
progenitor populations have been observed in response to Wnt
signaling during zebrafish development (Goessling et al.,
2008). These reciprocal effects of Fgf, Bmp, and Wnt signals
on liver and pancreas progenitor populations suggest that these
signals act on common endodermal progenitors to specify one
fate at the cost of the other. Indeed, a population of bipotential
progenitors has been delineated by single-cell-lineage labeling
in embryonic mouse (Miki et al., 2012; Spence et al., 2009; Trem-
blay and Zaret, 2005) and zebrafish (Chung et al., 2008). In
mouse, single-cell labeling of anterior endoderm at early somite
stages, prior to expression of organ-specific markers, identified
bipotential progenitors as well as closely interspersed ventral
pancreas and liver progenitors (Miki et al., 2012; Tremblay and
Zaret, 2005). Although these studies map bipotential progenitors
and the timing of their segregation into a liver or pancreas
anlagen, it is thought that the fates of these segregated popula-
tions might be reversible in early somite stages such that modu-
lation of extrinsic signals can shift one fate into another (Miki
et al., 2012). In zebrafish, endodermal cells capable of both a
liver and exocrine pancreas fate have been identified at the
six- to eight-somite stage (Chung et al., 2008). Although these
labeling studies localize bipotential progenitors, how this popu-
lation spatially relates to multiple signals that regulate liver
versus pancreas specification is poorly understood.
Prostaglandin molecules have long been recognized as lipid-
derived cytokines that modulate diverse biologic processes
including vasoregulation, inflammation, and pain (Funk, 2001).
In addition, we recently described prostaglandin E2 (PGE2) as aental Cell 28, 423–437, February 24, 2014 ª2014 Elsevier Inc. 423
Figure 1. PGE2 Affects Embryonic Liver Outgrowth
(A) In situ hybridization for transferrin, a liver-specific marker, reveals that embryonic liver size is regulated by PGE2. Exposure to dmPGE2 from 48 to 80 hpf
dramatically increases embryonic liver size (51.4% embryos with an enlarged liver; n = 18/35), whereas exposure to Indo decreases embryonic liver size (76.5%
embryos with a smaller liver; n = 26/34). Left lateral view; row below is magnified view.
(B) FACS quantification of GFP+ liver cells in lfabp:GFP embryos at 72 hpf following exposure to dmPGE2 or Indo. dmPGE2 increases the relative number of
liver cells, whereas Indo decreases the relative number of liver cells. (Data are represented as mean ± SEM; ***significant across treatment groups, ANOVA,
p = 0.0009.)
(C) Confocal microscopy visualization of the liver in lfabp:GFP embryos at 72 hpf following exposure to dmPGE2 or Indo. Exposure to dmPGE2 from 48 to 72 hpf
enlarges the developing liver, whereas exposure to Indo severely abrogates liver development. Left lateral view. (Data are represented as mean ± SEM; n = 5 per
treatment.)
(legend continued on next page)
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function (North et al., 2007). However, a role for prostaglandins
in developmental fate decisions and solid organ development
has not been appreciated, in part because in vivo effects cannot
be easily studied independent of maternal prostaglandins in
mammalian models. Likewise, there is little knowledge of the
spatiotemporal expression pattern of components of the prosta-
glandin pathway during development. In particular, despite a
wide body of knowledge of prostaglandin function in the adult
gastrointestinal tract, induction and function of components of
the prostaglandin pathway in relation to organogenesis of solid
endodermal tissues have not been described.
Here we demonstrate a role for PGE2 in regulating the
outgrowth of the liver and pancreas buds in vivo as they
emerge from the zebrafish gut endoderm.Moreover, we uncover
an earlier role for PGE2 in specification of endoderm into liver
versus pancreas progenitors. PGE2 likewise promotes a liver
fate at the cost of a pancreas fate in bipotential mouse embry-
onic endoderm, suggesting an evolutionarily conserved devel-
opmental role for PGE2. Similar to other canonical pathways
regulating organ development, we uncover exquisite spatial
and temporal patterning of PGE2 pathway components consis-
tent with a role in specifying bipotential endodermal cells. Finally,
we show that PGE2 modulates liver regeneration in adult zebra-
fish, demonstrating that the role of PGE2 in endodermal
outgrowth might have implications for regeneration of adult
endodermal derivatives. Together, this work reveals a role for a
lipid-derived signaling molecule with morphogenetic properties
that regulate endodermal fate decisions and proliferation during
development.
RESULTS
Prostaglandin Levels Affect Liver Development
The prostaglandin pathway was identified as a modifier of endo-
dermal organ development through a chemical genetic screen in
zebrafish (Garnaas et al., 2012). Specifically, modulators of PGE2
synthesis and signaling affected embryonic liver size: a larger
liver resulted from exposure to compounds that increase prosta-
glandin signaling activity, whereas a smaller liver size was
caused by compounds that decrease prostaglandin signaling.
To corroborate the screening results, we exposed zebrafish
embryos from 48 to 80 hours postfertilization (hpf) to a long-
acting derivative, 16,16-dimethyl-PGE2 (dmPGE2), or the nonse-
lective Cox inhibitor indomethacin (Indo), which has been shown
to suppress PGE2 production in zebrafish by mass spectrometry
(North et al., 2007). Exposure to dmPGE2 caused a striking in-
crease in embryonic liver size (51.4% embryos with larger liver;(D) Analysis of liver [volume] 3 [mean fluorescence intensity] visualized by conf
liver size and Indo to diminish embryonic liver size. (Data are represented as mea
p < 0.0001.)
(E) Histological analysis reveals that modulation of PGE2 levels changes embryon
views are shown in the insets). TUNEL analysis shows no apoptosis following mod
(F–I) Morpholino-mediated knockdown of PGE2 synthetic enzymes (F and G) or PG
fluorescence in lfabp:GFP embryos. Left lateral view. Impact on liver size is quan
and (I). (Data are represented as mean ± SEM; nR 30 per condition; significant b
without versus with dmPGE2; ****p < 0.0001, *p < 0.05, **p < 0.01, ***p < 0.001;
See also Figure S1.
Developmn = 18/35) as visualized by expression of transferrin at 80 hpf
(Figure 1A). A larger embryonic liver developed in the presence
of Cay10397, an inhibitor of 15-hydroxyprostaglandin dehydro-
genase (pgdh) that deactivates prostaglandins in vivo and aug-
ments endogenous prostaglandin levels (Figure S1E available
online). In contrast, exposure to Indo caused a dramatic
decrease in embryonic liver size (76.5% embryos with smaller
liver; n = 26/34), indicating a role for endogenous prostaglandin
activity in normal liver development (Figure 1A). Similarly, expo-
sure to the selective Cox1 inhibitor SC-560 or the selective Cox2
inhibitor NS-398 both resulted in a smaller embryonic liver (Fig-
ure S1E). The same effects were observed by visualizing fluores-
cence after treatment of liver fatty acid binding protein:GFP
(lfabp:GFP) liver reporter fish (Figures S1A and S1F), and these
effects were statistically significant by volumetric analysis of
confocal images (Figures 1C and 1D). Fluorescence-activated
cell sorting (FACS) analysis of these embryos demonstrated sta-
tistically significant changes in GFP+ liver cell number, but no
change in cell size or shape (Figure 1B). Hepatocyte number
was increased without changes in cell density or tissue architec-
ture following dmPGE2 exposure, as revealed by histological
analysis (Figure 1E; Figures S1B–S1D). Furthermore, visualiza-
tion of apoptotic cells in treated embryos showed no significant
differences in cell death that could explain effects on organ size
(Figure 1E). Visualization of mitotic figures marked by phospho-
histone H3 (pHH3+) in the liver bud of lfabp:GFP reporter fish
demonstrated an increase in cell proliferation following exposure
to dmPGE2 and a decrease in cell proliferation following expo-
sure to Indo, suggesting that the effect of PGE2 is in part medi-
ated by regulating proliferation (Figures S5D and S5E).
The impact of PGE2 was confirmed by modulation of the
prostaglandin synthetic pathway. Morpholino-mediated knock-
down of PGE2 synthesis enzymes cox1a, cox2a, and prosta-
glandin E synthase (pges) resulted in a smaller embryonic
liver as quantified by measuring liver size in lfabp:GFP
embryos at 72 hpf, and this effect was partially rescued by expo-
sure to dmPGE2 (Figures 1F and 1G; Figure S1G). Likewise,
selective pharmacologic blockade of Cox1 and Cox2 by
SC-560 and NS-398, respectively, both resulted in a smaller
embryonic liver, and this effect was partially rescued by PGE2
(Figures S1E and S1F). In contrast, knockdown or pharmaco-
logic blockade of pgdh led to a larger embryonic liver, which
was further augmented with exogenous dmPGE2 (Figures
S1E–S1G).
The effects of PGE2 are mediated via the G-protein-coupled
receptors EP2 and EP4 (Funk, 2001). We therefore tested
whether knockdown of these receptors could generate the
same phenotypic effects as reducing levels of PGE2. Indeed,ocal microscopy, corroborating the effect of dmPGE2 to increase embryonic
n ± SEM; n = 5 per treatment; ****significant across treatment groups, ANOVA,
ic liver size but does not alter liver morphology (n = 5 per treatment; magnified
ulation of PGE2 activity (n = 5 per treatment). The scale bar represents 100 mm.
E2 receptors ep2a and ep4a (H and I) alters liver development, as visualized by
tified by [area]3 [fluorescence intensity] in lfabp:GFP embryos as shown in (G)
y t test comparing each morpholino [MO] versus control and each morpholino
n.s., not significant.)
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Figure 2. PGE2 Affects Embryonic Pancreas Outgrowth
(A) In situ hybridization for trypsin, an exocrine pancreas-specificmarker, following exposure to dmPGE2 or Indo reveals that embryonic pancreas size is regulated
by PGE2. dmPGE2 increases exocrine pancreas size (57.6% embryos with an enlarged pancreas; n = 38/66), whereas Indo diminishes exocrine pancreas size
(70.6% embryos with a smaller pancreas; n = 36/51). Dorsal view.
(B) FACS quantification of GFP+ exocrine pancreas cells in elastase:GFP embryos at 96 hpf following exposure to dmPGE2 or Indo. dmPGE2 increases and Indo
decreases the relative number of exocrine pancreas cells. (Data are represented as mean ± SEM; ****significant across treatment groups, ANOVA, p < 0.0001.)
(legend continued on next page)
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sulted in a smaller embryonic liver, and this effect was only
partially rescued by exogenous addition of PGE2 (Figures 1H
and 1I). Moreover, combined knockdown of both the ep2a and
ep4a receptors more severely abrogated liver development (Fig-
ure 1I; Figure S1G). Whereas the combined knockdown of both
cox1a and cox2a synthetic enzymes could be partially rescued
by exogenous dmPGE2 (Figure 1G; Figure S1G), the combined
knockdown of both ep2a and ep4a receptors could not be
rescued by exogenous dmPGE2 (Figure 1I; Figure S1G), consis-
tent with PGE2 acting through these receptors to enlarge the
developing liver and further confirming the role of PGE2
signaling. These data provide in vivo demonstration that PGE2
activity modulates embryonic liver development.
Signaling through EP2 and EP4 is thought to regulate phos-
phorylation by increasing intracellular levels of cAMP and
activating the downstream effector kinase PKA (Funk, 2001).
Therefore, to test whether PGE2 acts through these downstream
effectors to promote liver outgrowth, zebrafish embryos were
exposed to forskolin, a cAMP activator, or H89, a PKA inhibitor,
from 48 to 72 hpf. Augmenting cAMP activity resulted in a larger
embryonic liver, whereas inhibiting PKA activity resulted in a
smaller embryonic liver (Figure S1H). Furthermore, the effect of
dmPGE2 to augment liver size was blunted by H89, whereas
the effect of Indo to diminish liver size was countered by forskolin
(Figure S1H). These data are consistent with PGE2 acting
through downstream effectors cAMP and PKA to promote liver
outgrowth.
Prostaglandin Levels Affect Pancreas Development
Given the shared origin of liver and pancreas from gut endoderm,
we next examined the impact of PGE2 on pancreas develop-
ment. Zebrafish embryos were exposed to dmPGE2 or Indo dur-
ing outgrowth of the exocrine pancreas from 48 to 84 hpf and
examined for markers of exocrine (trypsin, carboxypeptidase A)
or endocrine (insulin) differentiation. dmPGE2 caused a dramatic
increase in exocrine pancreas size, whereas Indo diminished
exocrine pancreas size or completely abrogated exocrine
marker expression (Figure 2A; Figure S2A). A statistically signif-
icant effect was confirmed by volumetric analysis of the exocrine
pancreas as visualized by confocal microscopy of transgenic
trypsin:GFP fish (Figures 2D and 2E). FACS analysis of
elastase:GFP reporter fish demonstrated statistically significant
changes in GFP+ exocrine pancreas cell number but no change
in cell size or shape (Figure 2B). In contrast, modulation of PGE2
levels had no observable effects on endocrine pancreas forma-(C) In situ hybridization for insulin following exposure to dmPGE2 or Indo (n > 30
(D) Confocal microscopy visualization of exocrine pancreas in trypsin:GFP emb
enlarges and Indo severely diminishes pancreas development (n = 5 per conditio
(E) Analysis of pancreas [volume]3 [mean fluorescence intensity] visualized by co
diminish embryonic pancreas size. (Data are represented as mean ± SEM; ****si
(F) Histological analysis reveals that modulating PGE2 levels changes embryo
(n = 5 per treatment). Shown are exocrine pancreas cells with apical accumulatio
(G and H) Morpholino-mediated knockdown of PGE2 synthetic enzymes or PGE2
partially rescued by addition of dmPGE2, as visualized by in situ hybridizat
receptors severely diminishes pancreas development, and this cannot be rescued
by [area]3 [fluorescence intensity] in trypsin:GFP fish as shown in (H). (Data are re
each morpholino treatment versus control and each morpholino treatment witho
See also Figure S2.
Developmtion as visualized by insulin expression (Figure 2C). No histolog-
ical differences in the exocrine pancreas were detectable in all
treated embryos (Figure 2F; Figure S2C) nor discernable effects
on cell death as assessed by TUNEL staining (Figure S2B).
We next tested whether inhibition of PGE2 synthesis enzymes
or receptors would similarly influence exocrine pancreas devel-
opment. Knockdown of cox1a, cox2a, or pges or exposure to
SC-560 or NS-398 abrogated development of the exocrine
pancreas visualized by expression of trypsin at 84 hpf, and this
effect was partially rescued by exogenous dmPGE2 (Figures
2G and 2H; Figure S2E). Knockdown of either ep2a or ep4a re-
sulted in a smaller exocrine pancreas, and this effect could
only be partially rescued by exogenous dmPGE2 (Figures 2G
and 2H). Again, combined knockdown of both receptors ep2a
and ep4a caused severe diminution of the developing exocrine
pancreas, and this effect could no longer be rescued by
dmPGE2, consistent with PGE2 acting through these receptors
to enlarge the developing pancreas (Figures 2G and 2H). Inhibi-
tion of PGE2 breakdown by the pgdh inhibitor Cay10397
augmented trypsin expression, demonstrating that, similar to
the liver bud, increasing endogenous PGE2 levels results in a
larger exocrine pancreas (Figure S2D). These data provide in vivo
evidence that levels of PGE2 modulate embryonic pancreas
development. Further experiments using dmPGE2 and Indo
and expression analysis of the intestinal marker intestinal fatty
acid binding protein (ifabp) demonstrated an impact on intestinal
development at 96 hpf (Figures S2F and S2G). These observa-
tions suggest that PGE2 activity might regulate the outgrowth
of other endodermal derivatives in addition to the liver and
pancreas.
Prostaglandin Has Reciprocal Effects on Liver versus
Pancreas Endodermal Specification
We have shown that prostaglandin activity is required for normal
development of the liver and pancreas and that augmenting
prostaglandin levels enlarges both the developing liver and
pancreas. These effects were observed when zebrafish embryos
were treated after 48 hpf, when liver and pancreas populations
have begun to express markers of mature differentiation. We
next sought to elucidate whether PGE2 had a similar role before
24 hpf, a period when markers of specified liver and pancreas
progenitors are first expressed but before differentiation and
expansion of these progenitors into specialized populations.
Zebrafish embryos were exposed to dmPGE2 at various time
frames before and after 24 hpf. Surprisingly, exposure between
12 and 20 hpf resulted in statistically significant opposing effectsper condition). Dorsal view.
ryos at 96 hpf following exposure to dmPGE2 or Indo. Exposure to dmPGE2
n). Right lateral view.
nfocal microscopy, corroborating the effect of dmPGE2 to increase and Indo to
gnificant across treatment groups, ANOVA, p < 0.0001.)
nic pancreas size without discernible changes in pancreas cell morphology
n of secretory granules.
receptors ep2a and ep4a abrogates pancreas development, and this effect is
ion for trypsin expression. Combined knockdown of both ep2a and ep4a
by addition of dmPGE2. Left lateral view. Impact on pancreas size is quantified
presented asmean ± SEM; n > 30 per condition; significant by t test comparing
ut versus with dmPGE2, ****p < 0.0001, ***p < 0.001; n.s., not significant.)
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Figure 3. PGE2 Influences Liver versus Pancreas Specification
(A) FACSquantification of liver and pancreas GFP+ cells in lfabp:GFP or elastase:GFP fish, respectively, at 96 hpf following exposure to dmPGE2 or Indo from 12 to
20 hpf. (Data are represented as mean ± SEM; significant across treatment groups, ANOVA, ****p < 0.0001, *p < 0.05.)
(B) Analysis of organ [volume]3 [fluorescence intensity] of the liver or pancreas in lfabp:GFP fish at 72 hpf or trypsin:GFP fish at 96 hpf, respectively, visualized by
confocal microscopy following treatment with dmPGE2 or Indo from 12 to 20 hpf. (Data are represented as mean ± SEM; significant across treatment groups,
ANOVA, ****p < 0.0001; n = 5 per condition.)
(C) Confocal microscopy of the liver at 72 hpf in lfabp:GFP fish or pancreas at 96 hpf in trypsin:GFP fish following exposure to dmPGE2 or Indo from 12 to 20 hpf.
Volume and fluorescence intensity are quantified in (B).
(D) Double in situ hybridization for trypsin (purple) + lfabp (brown) at 96 hpf reveals reciprocal effects on organ size following 12–20 hpf exposure to dmPGE2 or
Indo. Dorsal view. L, liver; P, pancreas.
(legend continued on next page)
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but smaller pancreas and Indo resulting in a smaller liver but
larger pancreas, as quantified by FACS analysis of lfabp:GFP
or elastase:GFP reporter fish (Figure 3A) and confocal volumetric
analysis (Figures 3B and 3C). The reciprocal effect on liver versus
pancreas size when PGE2 levels are modulated between 12 and
20 hpf contrasts with the effect observed after 24 hpf, when
impact on liver and pancreas size is in parallel.
We further explored this reciprocal effect by simultaneously
visualizing the emerging liver and pancreas buds marked by
the panendodermal marker foxa3 at 48 hpf as well as markers
of differentiated liver and pancreas cells at 96 hpf. Exposure to
dmPGE2 or Indo after 24 hpf confirmed a parallel effect; in
contrast, earlier exposure to these compounds at 12–20 hpf
had opposing effects on the developing liver and pancreas
buds (Figure 3E; Figure S3A). Exposure to dmPGE2 from 12 to
20 hpf enlarges the liver bud but diminishes the pancreas bud
at 48 hpf (Figure 3E), and larger liver but smaller pancreas organs
develop by 96 hpf (Figure 3D). Conversely, Indo treatment from
12 to 20 hpf results in smaller liver and larger pancreas buds at
48 hpf (Figure 3E), and smaller liver and but larger pancreas
organs are observed at 96 hpf (Figure 3D).
To investigate whether these reciprocal effects on the
nascent liver and pancreas organs ensue from effects on their
respective progenitor populations, we examined the impact
on endodermal progenitors specified to a liver or pancreas
fate. dmPGE2 exposure from 12 to 20 hpf diminished the
pancreas progenitor population marked by pdx1 but aug-
mented liver progenitors visualized with hhex (Figures 3F and
3G). Conversely, exposure to Indo from 12 to 20 hpf resulted
in a larger pancreas progenitor population but a diminished liver
progenitor population (Figures 3F and 3G). Quantification of
the area of pancreas progenitors marked by pdx1 or liver pro-
genitors visualized by hhex expression confirmed a statistically
significant change in response to modulating PGE2 activity (Fig-
ure 3H). To assess whether the observed effects of PGE2 activ-
ity on the size of the pancreas or liver progenitor populations at
20 or 28 hpf, respectively, are mediated by differential expan-
sion of progenitors, we quantified mitotic figures marked by
pHH3 at 18 hpf in sox17:GFP endoderm reporter fish. Modu-
lating PGE2 activity between 12 and 18 hpf results in no
significant changes in the number of pHH3+ sox17:GFP+ cells
(Figure S5A). These data suggest that the reciprocal effects of
early PGE2 activity on liver versus pancreas development are
caused by opposing effects on the specification of progenitor
populations.
Put together, these data uncover a biphasic role for PGE2
levels in liver and pancreas development. At the earlier phase
from 12 to 20 hpf before the liver and pancreas buds have
emerged, PGE2 expands the liver progenitor population but(E) In situ hybridization for foxa3 at 48 hpf reveals reciprocal effects on the liver and
indicated in orange and of the pancreas bud in blue. Dorsal view.
(F and G) Early exposure to dmPGE2 or Indo results in a smaller (89.1% of embry
pancreas progenitor cells visualized by pdx1 at 20 hpf, and a larger (68.6% of emb
of liver progenitor cells marked by hhex at 28 hpf. Dorsal view.
(H) Quantification of the area of pancreas progenitors or liver progenitors following
are represented as mean ± SEM; significant across treatment groups, ANOVA, *
See also Figure S3.
Developmdiminishes the pancreas progenitor population. This earlier
time frame corresponds to the stage when bipotential progeni-
tors capable of both liver and pancreas fates have been
identified (Chung et al., 2008). Therefore, these reciprocal
effects raise the possibility that PGE2 acts on bipotential endo-
dermal progenitors to promote a liver fate at the expense of a
pancreas fate.
Prostaglandin Affects Liver versus Pancreas
Specification of Murine Bipotential Endodermal
Progenitors
To directly test the hypothesis that PGE2 regulates the specifica-
tion of bipotential endodermal progenitors toward a liver fate at
the cost of a pancreas fate and suggests similar processes
across species, we derived a population of bipotential endo-
dermal progenitors through monolayer differentiation of mouse
embryonic stem cells. These bipotential progenitors express
the hepatopancreatic markers Hnf1b (Haumaitre et al., 2005;
Lokmane et al., 2008), Prox1 (Burke and Oliver, 2002), and
Onecut1 (Clotman et al., 2002; Jacquemin et al., 2003; Rausa
et al., 1997) as well as the pan-endodermal marker FoxA2 (Fig-
ure S4). Upon further differentiation, subpopulations of these
cells spontaneously express Hnf4a, a marker of hepatic specifi-
cation, or Pdx1, a marker of pancreatic specification. Manipula-
tion of transforming growth factor b (TGF-b) and Fgf signaling
allows enrichment of hepatic or pancreatic specification,
whereas both subpopulations arise spontaneously in ‘‘neutral’’
conditions (Figures S4A–S4C). When levels of PGE2 were
increased in neutral conditions by incubation with dmPGE2 or
Cay10397, differentiation into Pdx1+ cells decreased, whereas
differentiation into Hnf4a+ cells increased significantly (Figure 4).
In contrast, when levels of PGE2 were decreased by incubation
with Indo, SC-560, or NS-398, the majority of the population
was specified into a Pdx1+ pancreas fate but specification into
a liver fate was dramatically reduced (Figure 4). These effects
of PGE2 modulation occurred in as little as 16 hr, making it
unlikely that differential proliferation could explain the changes
in specification. Indeed, despite the statistically significant
changes in cell differentiation, cell density as quantified by
nuclear staining did not changewithmodulation of prostaglandin
activity (Figure 4C). Additionally, we quantified proliferation by
the percentage of FoxA2+ endoderm cells that were also
pHH3+ after 18 hr of pharmacologic PGE2 modulation and found
no statistically significant differences across the treatment con-
ditions (Figures S5B and S5C). These results suggest that low
levels or absence of PGE2 promotes pancreas specification,
whereas PGE2 is necessary for liver specification. Furthermore,
these results support the hypothesis that PGE2 regulates bipo-
tential endoderm progenitor differentiation toward a liver versus
pancreas fate across vertebrate species.pancreas buds emerging from the gut endoderm. The extent of the liver bud is
os; n = 41/46) or larger (95.1% of embryos; n = 39/41) domain, respectively, of
ryos; n = 35/51) or smaller (72.7% of embryos; n = 32/44) domain, respectively,
exposure to dmPGE2 or Indo during somitogenesis, shown as%control. (Data
**p < 0.001, *p = 0.013; n = 5 per treatment group.)
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Figure 4. Liver versus Pancreas Specification of Mouse Bipotential Endoderm Progenitors Is Influenced by PGE2
(A and B) Immunohistochemistry analysis of differentiating mouse endodermal progenitors following 24 hr exposure to various modulators of PGE2 activity.
Panendodermal cells marked by FoxA2 (red) are capable of either pancreas specification marked by Pdx1 (green in A) or liver specification marked by Hnf4a
(green in B). The scale bar represents 100 mm.
(C) The percentage of FoxA2+ cells that become Pdx1+ (blue) or Hnf4a+ (orange) following exposure to various modulators of PGE2 activity. (Data are represented
asmean ± SEM; significant compared to DMSOby ANOVA test, ***p < 0.001, *p < 0.05; three independent experiments.) Shown also is cell density as%of control
(pink), and differences are not significant by ANOVA test (p = 0.854).
See also Figures S4 and S5.
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Regulate Liver versus Pancreas Specification of
Endoderm
Having demonstrated in vivo and in the context of mouse bipo-
tential endoderm that PGE2 activity influences liver versus
pancreas specification, we next examined expression of compo-
nents of the prostaglandin pathway in relation to endodermal
progenitors.We first examinedmammalian expression bymicro-
array analysis in mouse embryonic stem cells at various stages
of differentiation, and confirmed that Ep2 and Ep4 expression
is enriched in a population of bipotential mouse endoderm rela-
tive to primitive ectoderm or lateral plate mesoderm (Figure 5A).
We further confirmed conserved enrichment of the PGE2 recep-
tors ep2a and ep4a in the zebrafish endoderm monolayer by
analysis of GFP+ cells sorted from a primitive endoderm reporter
fish, sox17:GFP, at the six- to eight-somite stage. We found that
ep2a is highly enriched in the zebrafish endoderm, consistent
with responsiveness to PGE2 in this population (Figure 5B). A
population of bipotential liver and exocrine pancreas progenitors
has been delineated by single-cell labeling in the endoderm
monolayer of zebrafish (Chung et al., 2008), located between
somites 1 and 3 at the six- to eight-somite stage. We therefore
examined expression of components of the prostaglandin
pathway in relation to this population of bipotential endodermal
cells. At 10 hpf, when somitogenesis is beginning, ep2a is
expressed in a population of cells adjacent to the notochord,
spanning four cells from themidline and localized along the ante-
rior-posterior axis in the region where the first somites will form
(Figure S6A). Remarkably, at the six-somite stage (12 hpf), the
PGE2 receptor ep2a is localized to endoderm between somites
1 and 3 in a population of cells spanning four cells from the
midline (Figure 5C; Figures S6C and S6D), colocalized with the
population of bipotential progenitors (Chung et al., 2008). We
next examined expression of PGE2 synthesis components.
Expression of cox2a was found in a population of cells on the
lateral edge of the population expressing ep2a (Figure 5C; Fig-
ure S6A). Expression of cox1awas found in a broader population
of cells even more lateral to the ep2a-expressing cells (Fig-
ure S6B). Expression of other PGE2 pathway genes including
the receptor ep4a and the degrading enzyme pgdh did not
appear to be specifically patterned in relation to the population
of bipotential progenitors during early somitogenesis (Figure 5D;
Figure S6B). Because cox2a is known to be an inducible and
rate-limiting enzyme in PGE2 synthesis, this patterning of
cox2a expression is consistent with the highest levels of PGE2
occurring at the most lateral side of the ep2a-expressing cells
and lower levels of PGE2 occurring at the most medial aspect
of the ep2a-expressing cells.
Given the finding that the PGE2 receptors ep2a and ep4a are
differentially patterned during embryogenesis, we exposed
zebrafish embryos to receptor-selective agonists in order to
delineate the role of specific receptors at different stages of
development. Exposure to Ep1 or Ep3 agonists sulprostone or
Ono 248, respectively, had no significant impact on developing
pancreas or liver size (Figure 5E). In contrast, exposure to
selective Ep2 agonists butaprost or Ono 259 during somitogen-
esis 12–20 hpf results in a smaller pancreas but larger liver (Fig-
ure 5E), similar to dmPGE2. Moreover, exposure to a selective
Ep4 agonist, Ono 329, during somitogenesis has no significantDevelopmimpact on developing pancreas or liver size (Figure 5E), consis-
tent with expression of ep2a but not ep4a corresponding to the
population of bipotential endodermal progenitors. At later time
points during organ outgrowth, we have shown that exposure
to dmPGE2 results in a larger pancreas and liver (Figures 3A–
3D). Exposure to the Ep4 agonist Ono 329 at 48–96 hpf results
in a larger pancreas and liver organ (Figure 5G). In contrast, no
significant effects on developing pancreas or liver size were
observed following exposure to selective Ep2 agonists butaprost
or Ono 259 (Figure 5G). Consistent with these receptor-specific
effects, we find that ep4a but not ep2a is expressed in the devel-
oping liver bud during liver outgrowth (Figure 5F). Put together,
these expression patterns and receptor-specific functional
data suggest that the specificity and changing roles of PGE2
through development are dictated by receptor localization.
We have previously demonstrated the importance of develop-
mental signaling pathways for liver regeneration (Goessling et al.,
2008). Having shown a significant role for PGE2 during embry-
onic liver outgrowth, we examined whether PGE2 impacts adult
liver regeneration. Partial hepatectomieswere performed in adult
fish, and regrowth was quantified after exposure to PGE2 modi-
fiers. We found that PGE2 regulates adult liver regeneration and,
similar to embryonic liver outgrowth, this role is predominantly
mediated via the ep4a receptor (Figures S6E and S6F). Similar
to the developmental context of liver bud outgrowth, PGE2 reg-
ulates cell proliferation in the regenerating liver (Figure S6G).
These data suggest that the developmental role for PGE2 in liver
outgrowth might be recapitulated in the context of adult liver
regeneration.
Prostaglandin and Bmp Signaling Pathways Interact to
Regulate Liver versus Pancreas Specification
Much like the impact of prostaglandin described here, Bmp
signaling has been shown to promote hepatic versus pancreatic
fate in bothmouse (Rossi et al., 2001) and zebrafish (Chung et al.,
2008) embryonic endoderm. Moreover, similar to cox2a at the
six- to eight-somite stage, bmp2b expression is spatially regu-
lated in two bilateral stripes at the ten-somite stage and affects
liver versus pancreas specification (Chung et al., 2008). Given
these parallels in both timing and pattern of expression, we
explored the possibility that these pathways interact to regulate
liver versus pancreas specification. Exposure to Indo from 12 to
20 hpf diminishes bmp2b expression in the lateral plate meso-
derm at 20 hpf, whereas exposure to dmPGE2 increases expres-
sion of bmp2b (Figure 6A). This finding demonstrates that PGE2
activity can regulate bmp2b expression, and therefore suggests
that the prostaglandin pathway might be acting via bmp2b
signaling to regulate liver versus pancreas specification. To
further test this possibility, we modulated both prostaglandin
activity as well as bmp2b activity and assayed the impact on
pancreas specification marked by pdx1. As previously reported,
activation of bmp2b in heat-shock-inducible hs:bmp2b trans-
genic fish diminishes the pancreas progenitor population
marked by pdx1 (Chung et al., 2008; Figures 6B and 6C). In
contrast, inhibition of bmp signaling by exposure to dorsomor-
phin, an inhibitor of bmp receptors alk 2, 3, and 6, or by activation
of a dominant-negative bmp receptor in heat-shock-inducible
hs:dnBmpR transgenic fish dramatically promotes the pancreas
progenitor population (Figures 6B and 6C). In support of aental Cell 28, 423–437, February 24, 2014 ª2014 Elsevier Inc. 431
Figure 5. Prostaglandin Pathway Genes Are Patterned to Regulate Endoderm Specification
(A)Microarray analysis reveals enrichment of Ep2 andEp4 in bipotential endodermprogenitors compared to primitive ectoderm or lateral platemesodermderived
from mouse embryonic stem cells, shown in arbitrary units.
(B) Quantitative PCR analysis of sox17+ endodermal cells sorted from sox17:GFP zebrafish embryos reveals enrichment of ep2a compared to ep4a. (Data
represented as mean ± SEM; t test, *p < 0.05; n = 3.)
(legend continued on next page)
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taglandin pathway, the effect of dmPGE2 to promote pancreas
progenitors is blunted by bmp receptor blockadewith dorsomor-
phin or heat-shock induction of dnBmpR (Figures 6B and 6C).
Conversely, the effect of Indo to promote pancreas progenitors
is blunted following activation of bmp2b (Figures 6B and 6C).
These data support a model in which the prostaglandin and
bmp2b pathways interact to regulate liver versus pancreas
specification, and that PGE2 acts at least in part by positively
regulating bmp2b expression.
DISCUSSION
In this study, we uncover evidence of a role for PGE2 in embry-
onic development. Through genetic and chemical approaches
in zebrafish embryos, we provide in vivo demonstration that
PGE2 activity has a critical role in the specification and outgrowth
of the liver and pancreas. During early somitogenesis, we reveal
that PGE2 activity regulates specification of endoderm into a liver
versus pancreas fate. We further provide evidence suggesting
mammalian conservation of this role in the context of mouse
embryonic endoderm. Later in embryonic development, we
uncover a role for PGE2 activity in regulating outgrowth of the
liver and pancreas buds. In line with this role in regulating embry-
onic liver outgrowth, PGE2 activity influences liver regeneration
in the adult zebrafish.
PGE2 Regulates the Fate Specification of Bipotential
Endoderm
We show that PGE2 activity promotes a liver progenitor popula-
tion at the cost of a pancreas progenitor population. These find-
ings are consistent with a role for PGE2 in regulating cell-fate
decisions in a population of bipotential endodermal progenitors.
An alternative interpretation is that PGE2 activity might differen-
tially influence the proliferation or maintenance of endodermal
cells already specified to a liver or pancreas fate. In support of
the first model, the reciprocal effects of prostaglandin activity
occur at a stage when bipotential endodermal cells have been
delineated (Chung et al., 2008). Moreover, we examine a popu-
lation of mouse endodermal cells that can be specified into
both liver and pancreas fates, and show that modulating prosta-
glandin activity can shift this population predominantly into one
fate or the other. We show that in both the in vivo context of
zebrafish endoderm aswell as the in vitro context of mouse bipo-
tential endodermal cells, modulating prostaglandin activity does
not differentially alter cell proliferation. Put together, these obser-
vations argue that PGE2 acts on bipotential endodermal cells to
guide specification toward a liver fate versus a pancreas fate.(C) Double in situ hybridization for ep2a (purple) or cox2a (purple) and myod (bro
(D) Double in situ hybridization for ep2a (purple) or ep4a (purple) and myod (brow
(E) Size distribution of pancreas or liver progenitor domain following exposure to
20 hpf. Impact on pancreas progenitors was assessed at 20 hpf by in situ hybridiz
hybridization to hhex. The following pharmacologic agents were used: sulproston
(Ep2 agonist), and Ono 329 (Ep4 agonist). (*Significant versus control by c2 test,
(F) Expression of ep2a and ep4a at 72 hpf visualized by in situ hybridization. ep4
(G) Size distribution of pancreas or liver organs following exposure to pharmacolo
on pancreas outgrowth was assessed at 96 hpf by in situ hybridization to try
hybridization to lfabp. (*Significant versus control by c2 test, p < 0.05; n > 30 for
See also Figure S6.
DevelopmIn conjunction with our functional data, we reveal exquisite
patterning of genes in the prostaglandin signaling pathway
consistent with a key role in endodermal specification. The pros-
taglandin receptor ep2a is expressed in a population of endo-
derm corresponding to the previously characterized bipotential
progenitor population (Chung et al., 2008). This pattern raises
the intriguing possibility that ep2amight serve as an early marker
of liver-pancreas bipotential progenitors. Although studies in
zebrafish and mouse embryos have characterized the signals
directing the specification of this population, a marker for this
population has not been described. Our microarray data show
enrichment of Ep2 in mouse bipotential endoderm and suggest
that the patterning of ep2a in zebrafish might be conserved.
Understanding PGE2 as a Morphogen
Concomitant with patterning of ep2a, the rate-limiting enzyme in
PGE2 synthesis cox2a is patterned in two bilateral stripes such
that endodermal cells closest to this source of prostaglandin are
specified to become liver, whereas endodermal cells farther
from this source of prostaglandin are specified to become
exocrine pancreas. These findings lay the groundwork for under-
standing prostaglandin activity as a morphogen whereby a
gradient of prostaglandin activity might pattern a field of endo-
derm (Figure 7). This model makes several predictions. First,
although there is no direct way to visualize PGE2 in vivo, as has
been achieved with fluorescent fusion proteins (Mu¨ller et al.,
2012), we speculate that there might be a graded distribution of
the readily diffusible PGE2 molecule acting on the population of
ep2a-expressing cells based on the distinct spatial restriction
of cox2a expression. A morphogen gradient of another nonpepti-
dic signaling molecule, retinoic acid, has long been functionally
recognized but only recently was visually proven (Shimozono
et al., 2013). Prostaglandins are widely assumed to act as para-
crine hormones exerting effects by interacting with extracellular
receptors. However, although prostaglandin transport proteins
have been identified in the cell membrane, themechanisms regu-
lating prostaglandin exit fromcells and how far they act are poorly
understood (Schuster, 2002). Second, a prevailing view of mor-
phogen gradients postulates that uniform clearance across the
exposed tissue generates a decaying concentration gradient of
the morphogen (Rogers and Schier, 2011). Consistent with this
notion, expression of the PGE2-degrading enzyme pgdh is
uniform. Moreover, we show that targeted knockdown or phar-
macologic inhibition of this enzyme activity has phenotypic
consequences similar to augmentation of PGE2 levels. Third,
consistent with a morphogen model, our observations in mouse
bipotential endoderm suggest that this cell population has
different genetic responses to different levels of PGE2. High levelswn) in zebrafish embryos at the six-somite stage.
n) in zebrafish embryos at the six-somite stage.
pharmacologic agonists or antagonists of various PGE2 receptors from 12 to
ation to pdx1, and impact on liver progenitors was assessed at 28 hpf by in situ
e (Ep1 + Ep3 agonist), Ono 248 (Ep3 agonist), butaprost (Ep2 agonist), Ono 259
p < 0.05; n > 30 for each condition.)
a but not ep2a expression at 72 hpf corresponds to the emerging liver bud.
gic agonists or antagonists of various PGE2 receptors from 48 to 96 hpf. Impact
psin, whereas impact on liver outgrowth was assessed at 96 hpf by in situ
each condition.)
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Figure 6. PGE2 Interacts with the bmp2b Pathway to Regulate Liver versus Pancreas Specification
(A) Modulation of PGE2 levels from 12 to 20 hpf impacts expression of bmp2b in the lateral plate mesoderm as shown by in situ hybridization at 20 hpf. dmPGE2
increases bmp2b expression (n = 15/19 embryos), whereas Indo decreases bmp2b expression (n = 14/21 embryos). Lower: magnified view of the area in the
dashed square. bmp2b is also expressed in the otic vesicles (arrow).
(B and C) Size of pancreas-specified population marked by pdx1 is impacted by modulation of the PGE2 or bmp2b pathways. Representative views are shown in
(B), and quantification is shown in (C). dmPGE2 or heat-shock activation of bmp2b diminishes whereas Indo, dorsomorphin (Dorso), or heat-shock activation of
dnBmpR promotes the pancreas progenitor population. The impact of dmPGE2 is blunted by Dorso or dnBmpR, and the impact of Indo is blunted by heat-shock
activation of bmp2b. (Data are represented as mean ± SEM; n R 10 per condition; t test comparisons: *p < 0.05 comparing treatment versus control; #no
significant difference comparing with versus without dmPGE2;
##no significant difference comparing with versus without Indo.)
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The Role of PGE2 in Liver and Pancreas Developmentof PGE2 promote a liver specification program, whereas lower
levelsor absenceofPGE2promotesapancreasspecificationpro-
gram. A similar activity gradient regulating liver versus pancreas
specification has been postulated of bmp2b (Chung et al.,
2008), and indeed we find evidence for an interaction between
the PGE2 and bmp2b pathways. How different levels of PGE2
are transduced into a liver versus pancreas cell fate, and how434 Developmental Cell 28, 423–437, February 24, 2014 ª2014 Elsevthis activity gradient interactswithother signals known to regulate
liver and pancreas specification, remains to be elucidated.
Dynamic Roles for PGE2 in Different Developmental
Contexts
Our findings demonstrate that the role of PGE2 activity in the
context of liver and pancreas development changes over time.ier Inc.
Figure 7. Model for the Role of PGE2 Activity
in Liver versus Pancreas Endoderm Specifi-
cation
A model for PGE2 regulation of endodermal
specification into liver or pancreas progenitors.
Bipotential endodermal cells capable of both a
liver and an exocrine pancreas fate (red/blue cells)
have been found between somites 1 and 3. Levels
of PGE2 (green gradient) may form a gradient with
highest activity closest to the two bilateral stripes
of cox2a (solid green bands), the rate-limiting
enzyme in PGE2 synthesis. Cells closest to the
highest levels of PGE2 are more likely to acquire a
liver fate (red cells), whereas cells farther from the
source of PGE2 acquire an exocrine pancreas fate
(blue cells). Augmenting levels of PGE2 promotes a
liver fate at the cost of a pancreas fate, whereas
decreasing levels of PGE2 promotes a pancreas
fate at the cost of a liver fate.
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ingpathways that regulate liver andpancreasdevelopment.Shift-
ing roles in liver and pancreas development have been demon-
strated for Wnt, Shh, and Bmp signaling pathways, and these
changes can occur in just a few hours (Goessling et al., 2008;
Wandzioch and Zaret, 2009; Zaret and Grompe, 2008). Similarly,
in this study, we find a time frame during early somitogenesis in
which PGE2 activity regulates liver versus pancreas specification
of gut endoderm and a later phase in which PGE2 activity pro-
motes the expansion and outgrowth of both liver and pancreas
buds. A changing role for PGE2 might in part be governed by
exquisite spatial and temporal regulation of receptor expression
in different contexts. We find that ep2a and ep4a are differentially
patterned in different developmental contexts.Moreover, consis-
tent with their distinct expression, we demonstrate receptor-
specific effects of blocking ep2a or ep4a, and find that ep2a
has a critical role in regulating liver- versus pancreas-fate deci-
sions, whereas ep4a has a role in regulating outgrowth of the
liver and pancreas buds. In conjunction with carefully regulated
production, the regulation of receptor expression to dictate
shifting roles of secreted factors might be a common theme in
development. Delineating the role of prostaglandins at specific
stages of liver and pancreas organogenesis might help inform
how we tailor stem cell differentiation for therapy.The Role of PGE2 in Gastrointestinal Regeneration and
Cancer
A second fundamental property of signaling pathways that regu-
late solid organ development is their importance in the context of
regeneration and cancer (Goessling et al., 2008; Rhim and
Stanger, 2010). Indeed, in this study, we show that modulating
prostaglandin activity influences liver regeneration after adult
hepatectomy. These findings parallel our observations that
genetically or chemically diminishing prostaglandin activity abro-
gates outgrowth of the embryonic liver bud. Furthermore, consis-
tentwith our findings that excessprostaglandin activity promotes
growth of the embryonic pancreas bud and primordial intestine
marked by ifabp, dysregulation of the prostaglandin pathway is
a key feature of both pancreatic and colon cancer, and inhibitors
of COX synthetic enzymes have long been known to reduce the
occurrence anddeath fromcancers of the colon, lungs, andotherDevelopmendodermal derivatives (Rothwell et al., 2011; Wang and Dubois,
2010). Therefore, although prostaglandins have traditionally
been thought to promote cancer by augmenting inflammation
and angiogenesis, the findings presented in this study provide
an ontogenic context for investigating the role of prostaglandin
activity in gastrointestinal cancer and regeneration.
A New Understanding of PGE2 Function
A dynamic array of protein signaling factors has been implicated
in regulating specification of gut endoderm (Zaret and Grompe,
2008). Our findings place PGE2 among these canonical signaling
pathways, and thereby challenge long-standing notions of pros-
taglandin function. We demonstrate that, much like canonical
protein signaling pathways, the PGE2 pathway exhibits exquisite
spatial and temporal patterning of its synthetic enzymes and re-
ceptors, changing roles at different times in organogenesis, and
a role in adult organ homeostasis. Froman evolutionary perspec-
tive, prostaglandins have been found in prokaryotes and plants,
and thus predate the protein signaling pathways that regulate
development of metazoans (Richards and Degnan, 2009). We
postulate that prostaglandins offer unique ancestral advantages
compared to protein signaling pathways. Prostaglandins are
synthesized de novo from metabolism of membrane-derived
arachidonic acid, and therefore do not have the storage and
energy requirements of protein signaling pathways. Additionally,
prostaglandins are thought to have an evanescent half-life (Funk,
2001), and therefore might allow more temporally and spatially
accurate signaling between cells. The specification of endoderm
into liver or pancreas fates, in which regulatory signals must act
over the span of a few cells and in a small time window, is exem-
plary of such a sensitive and critical developmental process. Our
findings open the door to the discovery of additional develop-
mental programs regulated by prostaglandins and might offer
new therapeutic avenues for tissue repair and cancer treatment.
EXPERIMENTAL PROCEDURES
Zebrafish Husbandry
Zebrafish were maintained according to Institutional Animal Care and Use
Committee protocols. Transgenic lines lfabp:GFP, lf:dsRed;elastase:GFP,
gut:GFP, trypsin:GFP, hs:bmp2b, and hs:dnBmpR were described previously
(Chung et al., 2008; Goessling et al., 2008; Korzh et al., 2008). Heat shock ofental Cell 28, 423–437, February 24, 2014 ª2014 Elsevier Inc. 435
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The Role of PGE2 in Liver and Pancreas Developmenths:bmp2b fish or hs:dnBmpR fish at 12 hpf was performed at 37C or 40C for
30 min as previously described (Chung et al., 2008).
Embryonic Zebrafish Experiments
Embryos were exposed to pharmacologic agents at the time points described
at a concentration of 10 mM except for 30 mM dorsomorphin, 0.5 mM H89, and
0.5mMforskolin.DMSOcarrier contentwas0.1%.Embryoswereprocessed for
in situ hybridization using standard protocols (http://zfin.org/ZFIN/Methods/
ThisseProtocol.html). Morpholino (GeneTools) knockdown was performed as
previously described (North et al., 2007). Embryos were processed for whole-
mount immunohistochemistry using standard protocols and antibodies against
pHH3 (Millipore; titer 1:500) and GFP (Millipore; titer 1:300). For section immu-
nohistochemistry, hematoxylin and eosin staining was performed on alternate
sections using standard techniques as previously described (Goessling et al.,
2008). Antibodies to proliferating cell nuclear antigen (AnaSpec; titer 1:200)
were visualized by 3,30-diaminobenzidine and counterstained with methyl
green. Apoptosis was visualized using the ApopTag kit (Chemicon).
Adult Zebrafish Experiments
Liver resection was performed and regeneration was evaluated as previously
described (Goessling et al., 2008). Adult zebrafish were fixed with paraformal-
dehyde, paraffin embedded, and cut in 10 mm sections for histological anal-
ysis. Hematoxylin and eosin staining was performed on alternate sections
using standard techniques as previously described (Goessling et al., 2008).
Quantification of Liver or Pancreas Size
Liver or pancreas size was quantified by FACS of GFP+ cells in fluorescent
reporter fish, confocal microscopy, and volumetric analysis, and measure-
ment of the area of marker expression was visualized by in situ hybridization
using ImageJ (National Institutes of Health). Volumetric analysis incorporated
volume and average fluorescence intensity of 3D confocal stacks using
ImageJ.
Flow Cytometry Analysis
Whole fluorescent embryos were manually dissociated in 0.25% trypsin for
20 min and then analyzed for % GFP fluorescence by flow cytometry. At least
100,000 cells were analyzed per sample (n = 10–20 per treatment).
Quantitative PCR
Quantitative PCR was performed using primer sets for pdx1, ep2a, and ep4a.
RNA was extracted and RT-PCR was performed as previously described
(Goessling et al., 2009).
Mouse Embryonic Stem Cell Differentiation, Treatment, and
Immunohistochemistry
Mouse embryonic stem cell culture and stepwise differentiation into endoderm
and then bipotential hepatopancreatic progenitors were performed according
to previously published protocols (Sherwood et al., 2011) as schematized in
Figure S4 and detailed in Supplemental Experimental Procedures.
Microarray
Bipotential hepatopancreatic progenitors were derived from mouse embry-
onic stem cells as described, processed for microarray using the Illumina
TotalPrep RNA Amplification Kit (Ambion), and hybridized to MouseRef-8
v2.0 chips (Illumina). Microarray values were compared with previously
obtained microarray data (R. Sherwood, personal communication) using
GenomeStudio software (Illumina).
Statistical Analysis
Pooled data were calculated asmean ± SE, with the number of repeats as indi-
cated. Pairwise comparison was performed by t test, multiple comparisons by
ANOVA, and distribution comparisons by c2 test.
SUPPLEMENTAL INFORMATION
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and six figures and can be found with this article online at http://dx.doi.org/
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